Analyst Ratings for MAIA Biotechnology (MAIA)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/21/2023 | Noble Capital | Robert LeBoyer | New Coverage | Outperform (N/A) |
14.00 (N/A) |
4.53 (1.54) |
-66% | Details |
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/21/2023 | Noble Capital | Robert LeBoyer | New Coverage | Outperform (N/A) |
14.00 (N/A) |
4.53 (1.54) |
-66% | Details |